Glaucoma News

Overdiagnosis and overtreatment are growing problems in glaucoma, and ophthalmologists must work toward finding solutions, according to a lecturer at the American Glaucoma Society meeting.

WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Renee Bovelle, MD, discusses the benefits of using Iyuzeh to treat glaucoma while not inducing dry eye.

FRANKFURT, Germany — In this Healio Video Perspective from the ESCRS winter meeting, Aylin Kiliç, MD, predicts that customized additive strategies will be the future of refractive surgery.

The travoprost intraocular implant demonstrated a reduction in IOP in patients with open-angle glaucoma or ocular hypertension 3 months after a single administration, according to a study published in Ophthalmology.

ATLANTA — An expert panel at SECO 2024 agreed that artificial intelligence will have a role in patient care but will not replace the human component.

ATLANTA — Secondary glaucomas are related to aqueous outflow and can require closer management, Mitch Ibach, OD, FAAO, said at SECO 2024.

Modern glaucoma care is all about the patient, according to a speaker at the American Glaucoma Society meeting.

TAMPA, Fla. — In this Healio Video Perspective from Telling It Like It Is, Steven R. Sarkisian Jr., MD, explains why endoscopic cyclophotocoagulation, or ECP, is still a “powerful tool” for glaucoma treatment.

Skye Bioscience has completed enrollment for its phase 2a trial of SBI-100, a cannabinoid receptor type 1 agonist being developed for patients with primary open-angle glaucoma or ocular hypertension, according to a company press release.

A large language model chatbot matched and even outperformed fellowship-trained ophthalmologists in diagnostic and treatment accuracy of retina and glaucoma cases, according to new research published in JAMA Ophthalmology.